Literature DB >> 15917185

Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy.

Isabelle Hininger1, Robert Waters, Mireille Osman, Catherine Garrel, Karen Fernholz, Anne Marie Roussel, Richard A Anderson.   

Abstract

Chelation therapy is thought to not only remove contaminating metals but also to decrease free radical production. EDTA chelation therapy, containing high doses of vitamin C as an antioxidant, is often used in the treatment of diseases such as diabetes and cardiovascular diseases but the effectiveness of this treatment may be variable and its efficacy has not been demonstrated conclusively. The objective of this work was to determine if the vitamin C added to standard chelation therapy cocktails was prooxidant. We administered a standard EDTA cocktail solution with or without 5 g of sodium ascorbate. One hour following the standard chelation therapy, there were highly significant prooxidant effects on lipids, proteins, and DNA associated with decreased activities of RBC glutathione peroxidase and superoxide dismutase while in the absence of sodium ascorbate, there were no acute signs of oxidative damage. After 16 sessions of standard chelation therapy, the acute prooxidant effects of vitamin C remained, but, even in the absence of nutrient supplements, there were beneficial long-term antioxidant effects of chelation therapy and plasma peroxide levels decreased. In conclusion, multiple sessions of EDTA chelation therapy protect lipids against oxidative damage. However, standard high amounts of vitamin C added to EDTA chelation solutions also display short term prooxidant effects. The added benefits of lower levels of vitamin C in chelation therapy need to be documented.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917185     DOI: 10.1016/j.freeradbiomed.2005.02.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  16 in total

Review 1.  Biomarkers of exposure to vitamins A, C, and E and their relation to lipid and protein oxidation markers.

Authors:  Lars O Dragsted
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

2.  Ethylenediaminetetraacetic acid induces antioxidant and anti-inflammatory activities in experimental liver fibrosis.

Authors:  J González-Cuevas; J Navarro-Partida; A L Marquez-Aguirre; M R Bueno-Topete; C Beas-Zarate; J Armendáriz-Borunda
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

3.  Reversible reduction of nitroxides to hydroxylamines: roles for ascorbate and glutathione.

Authors:  Andrey A Bobko; Igor A Kirilyuk; Igor A Grigor'ev; Jay L Zweier; Valery V Khramtsov
Journal:  Free Radic Biol Med       Date:  2006-11-10       Impact factor: 7.376

4.  Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum.

Authors:  Brian H Harvey; Charise Joubert; Jan L du Preez; Michael Berk
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

5.  Oxalic acid excretion after intravenous ascorbic acid administration.

Authors:  Line Robitaille; Orval A Mamer; Wilson H Miller; Mark Levine; Sarit Assouline; David Melnychuk; Caroline Rousseau; L John Hoffer
Journal:  Metabolism       Date:  2009-02       Impact factor: 8.694

Review 6.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

7.  Pro-oxidant effect of alpha-tocopherol in patients with type 2 diabetes after an oral glucose tolerance test--a randomised controlled trial.

Authors:  Mark S Winterbone; Mike J Sampson; Shikha Saha; Jackie C Hughes; David A Hughes
Journal:  Cardiovasc Diabetol       Date:  2007-02-22       Impact factor: 9.951

8.  Protective effect of EDTA preadministration on renal ischemia.

Authors:  Chiara Foglieni; Alessandro Fulgenzi; Paolo Ticozzi; Fabio Pellegatta; Clara Sciorati; Daniela Belloni; Elisabetta Ferrero; Maria Elena Ferrero
Journal:  BMC Nephrol       Date:  2006-03-15       Impact factor: 2.388

9.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

10.  Liver mitochondrial function in ZDF rats during the early stages of diabetes disease.

Authors:  Guillaume Vial; Marie Le Guen; Frédéric Lamarche; Dominique Detaille; Cécile Cottet-Rousselle; Luc Demaison; Isabelle Hininger-Favier; Pierre Theurey; David Crouzier; Jean-Claude Debouzy; Hervé Dubouchaud; Éric Fontaine
Journal:  Physiol Rep       Date:  2016-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.